Many studies propose better outcomes after bacteriotherapy by using
L. plantarum, e.g. in animal models of
P. aeruginosa infected burn wounds or chronic wounds in diabetic mice. Even a topically applied prophylactic administration of
L. plantarum induced a health benefit [
17,
30,
32]. Some in-vitro studies using surface-attached biofilms, challenged the pathogens to different types of living lactic acid-producing bacteria as well as supernatants or isolated proteins, and confirmed the antimicrobial activity and healing-promoting effects [
33‐
39]. The success was dependent on the applied pathogens and probiotics and their concentrations. However, there is a great need for research addressing the potential of bacteriotherapy and the understanding of the mechanisms in more detail. This study transferred the investigation to the newly established human plasma biofilm model. The selection of pathogenic bacteria was based on the WHO list of priority pathogens for R&D of new antibiotics published in February 2017 [
15]. Additionally, a fungal contamination with
C. albicans was examined.
Plasma preserves from different donors were used for the investigation. The results were not pooled, due to the different immune competences of the donors and the potential influence on the antimicrobial efficiency. In the hpBIOM, it was possible to demonstrate and to confirm the enormous antimicrobial efficiency of
L. plantarum towards
Pseudomonas infections (Fig.
2a). By means of SEM, it was possible to visualize the migration into the biofilm and direct pathogen-probiotic interaction (Fig.
5a, b). Furthermore,
L. plantarum extensively produced a glycokalyx, which seemed to cover and destroy
Pseudomonas (Fig.
5c). Supplementation of
L. plantarum to
S. aureus,
S. epidermidis and
E. faecium also induced slight but significant growth reductions (Fig.
2b–d), which was not shown before. The exact mechanisms resulting in the reduction or elimination of these bacteria is currently under investigation in this system. Different possibilities are postulated in other publications. For instance, different lactobacilli species have anti-elastase activity against
P. aeruginosa [
33]. Additionally, the effects of
L. plantarum were assigned to the secretion of antimicrobial substances, like 4,5-dihydroxy-2,3-pentanedione and 2-methyl-2,3,3,4-tetrahydroxytertahydrofurane, which inhibits quorum sensing [
38]. Other antimicrobial substances like hydrogen peroxide, benzoic acid or lactic acid are also secreted by
L. plantarum [
36]. The effect was donor- and time-specific, and thereby considered to be dependent on the immune system of the donor. This thesis was already proved in the gut, where different Bifidobacteria as well as Lactobacilli exerted stimulatory effect on the immune system [
16]. This has to be evaluated in progressive studies. Additionally, the constitution of the bacterial cell membrane seems to be a limiting factor, because the highest growth-reducing effects were detected against gram-negative bacteria. The growth rate of
C. albicans was not affected (Fig.
2e). This species is also surrounded by a strong cell wall. Interestingly,
B. lactis also exerted a reducing activity towards
Pseudomonas and
E. faecium (Fig.
3a, d) and even the yeast
S. cerevisiae showed slight but significant inhibitory effects on
S. aureus,
S. epidermidis and
E. faecium (Fig.
4b–d). These capacities were not yet determined in human biofilms. Although the reduction of the bacterial burden seemed not to be tremendous in some combinations, it can have major relevance for the wound therapy, because it enhances the chance of reducing bacterial load by the individual immune system. Further tests with a higher number of probiotics or their combinations will be performed, to examine, whether this will improve antimicrobial outcome.
Summarized, this study successfully reproduced a novel human biofilm model. This system still represents an in-vitro model and bares limitations like a time-limited stability or the lack of skin cells. Nevertheless, several improvements were developed compared to current biofilm models. It involves essential factors for analysing biofilms in a translational research approach, namely the individual immune competence and a human wound environment. By means of the hpBIOM, it was possible to systematically screen growth-reducing activity of three probiotics towards five clinically relevant pathogens. It was possible to visualize the elimination process of L. plantarum against P. aeruginosa. Finally, additional insights into the influence of the probiotic microorganisms B. lactis and S. cerevisiae could be efficiently obtained. These effects are described for this study design and could be differ after using other concentrations of probiotics or pathogens, respectively. In future studies, the investigation of bacteriotherapy by means of the hpBIOM should be expanded with regard to subcellular and molecular insights. Additionally, the portfolio of probiotics should be increased and in particular, combined therapies of L. plantarum and other effective probiotics should be investigated using the hpBIOM.